FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Aequita Pharmacy Semaglutide + Cyanocobalamin 0 Recall

Semaglutide + Cyanocobalamin 0

AEQUITA PHARMACY · Kirkland, WA

Risk level
Class II
Reported by FDA
Aug 13, 2025
Recall ID
D-0562-2025
Check your lot numberHow we source this data

Summary

Aequita Pharmacy recalled Semaglutide + Cyanocobalamin 0 starting Jul 18, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0562-2025 on Aug 13, 2025. Reason: Lack of Processing Controls. Status: Ongoing.

Why it was recalled

Lack of Processing Controls.

Product description

Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

Lot numbers, UPCs & expiration codes

All Lots within expiry.

Where it was sold

MA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0562-2025
Classification
Class II
Status
Ongoing
Recall initiated
Jul 18, 2025
FDA report date
Aug 13, 2025
Quantity
194 vials
Recall type
Voluntary: Firm initiated
Recalling firm
AEQUITA PHARMACY

Original FDA data

Every field from FDA enforcement report D-0562-2025, exactly as published.

Show all FDA fields
City
Kirkland
State
WA
Status
Ongoing
Country
United States
Event ID
97292
Address
12825 Ne 126th Pl
Code information
All Lots within expiry.
Postal code
98034-7721
Report date
Aug 13, 2025
Product type
Drugs
Recall number
D-0562-2025
Classification
Class II
Recalling firm
AEQUITA PHARMACY
Product quantity
194 vials
Reason for recall
Lack of Processing Controls.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Distribution pattern
MA
Recall initiation date
Jul 18, 2025
Initial firm notification
E-Mail
Center classification date
Aug 1, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0562-2025, published Aug 13, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls